NDC 0069-0324

NYVEPRIA

Pegfilgrastim-apgf

NYVEPRIA is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Pegfilgrastim.

• Product ID: 0069-0324_1995cf41-7843-4402-a82b-c093f249c016
• NDC: 0069-0324
• Product Type: Human Prescription Drug
• Proprietary Name: NYVEPRIA
• Generic Name: Pegfilgrastim-apgf
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2020-12-15
• Marketing Category: BLA / BLA
• Application Number: BLA761111
• Labeler Name: Pfizer Laboratories Div Pfizer Inc
• Substance Name: PEGFILGRASTIM
• Active Ingredient Strength: 6 mg/.6mL
• Pharm Classes: Granulocyte Colony-Stimulating Factor [CS],Granulocyte-Macrophage Colony-Stimulating Factor [CS],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0069-0324-01

1 CARTON in 1 CARTON (0069-0324-01) > 1 SYRINGE in 1 CARTON > .6 mL in 1 SYRINGE

• Marketing Start Date: 2020-12-15
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details